Nobel 2026 breakthrough restores vision
The genetic optics technique that the three scientists awarded the 2026 Nobel Prize in Medicine demonstrated promising results in a clinical trial for treating inherited blindness. Seven participants were able to improve their eyes' sensitivity to light, with six experiencing clinical improvements. Some patients succeeded in performing simple visual tasks such as locating objects and reaching towards them. This technology involves introducing a light-sensitive protein into the remaining retinal cells using gene therapy, allowing these cells to respond to light and convert it into visual signals that the brain can interpret. Although still experimental and not providing fully natural vision, the goal of the treatment is to replace the function of the lost photoreceptor cells in patients with retinitis pigmentosa, a genetic disorder that threatens the vision of over 1.5 million people worldwide. The approach focuses on the remaining neural pathways to transmit visual signals to the brain, with noticeable improvements in light sensitivity and performance in some visual tasks, though face recognition ability remains unavailable.
Notice: This Is an AI-Generated Summary
Comments (0)